• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素与生长因子信号通路之间相互作用的分子机制。

Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways.

作者信息

Kato S, Kitamoto T, Masuhiro Y, Yanagisawa J

机构信息

Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, Japan.

出版信息

Oncology. 1998 Dec;55 Suppl 1:5-10. doi: 10.1159/000055253.

DOI:10.1159/000055253
PMID:9852396
Abstract

The actions of estrogen (E2) are considered to be mediated through its nuclear E2 receptor (ER). In cancer development, growth factors are shown to act synergistically with E2. Recently, we found that the mitogen-activated protein kinase, activated by growth factors, phosphorylates human ERalpha and this phosphorylation potentiates the transactivation function of human ERalpha demonstrating a novel cross-talk between E2 and growth factor-signaling pathways. In this review, the molecular mechanism of this cross-talk is discussed.

摘要

雌激素(E2)的作用被认为是通过其核雌激素受体(ER)介导的。在癌症发展过程中,生长因子被证明与E2协同作用。最近,我们发现由生长因子激活的丝裂原活化蛋白激酶可使人类ERα磷酸化,这种磷酸化增强了人类ERα的反式激活功能,证明了E2与生长因子信号通路之间存在一种新的相互作用。在这篇综述中,将讨论这种相互作用的分子机制。

相似文献

1
Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways.雌激素与生长因子信号通路之间相互作用的分子机制。
Oncology. 1998 Dec;55 Suppl 1:5-10. doi: 10.1159/000055253.
2
MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.丝裂原活化蛋白激酶/雌激素受体相互作用增强雌激素介导的信号传导和肿瘤生长,但不赋予他莫昔芬耐药性。
Oncogene. 2002 Jun 6;21(25):4000-8. doi: 10.1038/sj.onc.1205506.
3
Estrogen receptor-mediated cross-talk with growth factor signaling pathways.雌激素受体介导的与生长因子信号通路的相互作用。
Breast Cancer. 2001;8(1):3-9. doi: 10.1007/BF02967472.
4
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.人乳腺癌中胰岛素样生长因子信号的增强:雌激素在体外和体内对胰岛素受体底物-1表达的调控
Mol Endocrinol. 1999 May;13(5):787-96. doi: 10.1210/mend.13.5.0274.
5
Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways.
Genes Cells. 2000 Aug;5(8):593-601. doi: 10.1046/j.1365-2443.2000.00354.x.
6
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.雌激素与人类乳腺癌和非小细胞肺癌细胞中生长因子受体的相互作用。
Steroids. 2005 May-Jun;70(5-7):372-81. doi: 10.1016/j.steroids.2005.02.017. Epub 2005 Mar 25.
7
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.对雌激素剥夺的获得性抗性:在新的MCF-7X模型中揭示生长因子信号激酶/雌激素受体相互作用的作用
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S85-97. doi: 10.1677/erc.1.01006.
8
Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.升高的ERK1/ERK2/雌激素受体相互作用增强长期雌激素剥夺期间雌激素介导的信号传导。
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S75-84. doi: 10.1677/erc.1.01023.
9
Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.雌激素作用与细胞质信号通路。第二部分:生长因子和磷酸化在雌激素信号传导中的作用。
Trends Endocrinol Metab. 2002 Dec;13(10):422-7. doi: 10.1016/s1043-2760(02)00634-3.
10
Cross-talk between peptide growth factor and estrogen receptor signaling pathways.肽生长因子与雌激素受体信号通路之间的相互作用。
Biol Reprod. 1998 Mar;58(3):627-32. doi: 10.1095/biolreprod58.3.627.

引用本文的文献

1
Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.在PAR1信号传导的背景下整合GPCR反式激活依赖性和偏向性信号传导模式。
Br J Pharmacol. 2016 Oct;173(20):2992-3000. doi: 10.1111/bph.13398. Epub 2016 Feb 16.
2
Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.雌激素受体β通过抑制 EGFR 发挥抑瘤作用并影响吉非替尼治疗反应的人恶性胸膜间皮瘤。
PLoS One. 2010 Nov 29;5(11):e14110. doi: 10.1371/journal.pone.0014110.
3
Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
4-羟基他莫昔芬诱导的细胞死亡需要延迟和持续的ERK1/2激活。
Steroids. 2007 Oct;72(11-12):765-77. doi: 10.1016/j.steroids.2007.06.007. Epub 2007 Jul 7.
4
PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.PTEN免疫组化表达在子宫体G1期子宫内膜样腺癌中受到抑制。
J Cancer Res Clin Oncol. 2004 Mar;130(3):161-8. doi: 10.1007/s00432-003-0517-8. Epub 2003 Dec 20.
5
Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells.IV型胶原蛋白和层粘连蛋白-1调节小鼠乳腺上皮细胞中雌激素受体α的表达和功能。
J Cell Sci. 2003 Jul 15;116(Pt 14):2975-86. doi: 10.1242/jcs.00523.
6
Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.表皮生长因子受体与雌激素受体的酪氨酸磷酸化
Endocrine. 2001 Nov;16(2):73-81. doi: 10.1385/ENDO:16:2:073.
7
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.成骨细胞中的胰岛素受体底物-1对于维持骨转换必不可少。
J Clin Invest. 2000 Apr;105(7):935-43. doi: 10.1172/JCI9017.
8
Antiestrogens--tamoxifen, SERMs and beyond.抗雌激素药物——他莫昔芬、选择性雌激素受体调节剂及其他。
Invest New Drugs. 1999;17(3):285-311. doi: 10.1023/a:1006348907994.
9
Modulating nuclear receptor function: may the phos be with you.调节核受体功能:愿“磷酸化”与你同在。
J Clin Invest. 1999 Jun;103(12):1617-8. doi: 10.1172/JCI7421.